BEUDAMED
    FDA Adverse Event Injury Summary report: N

    ZOLL IVTM COOL LINE CATHETER

    MDR report key: 6675559 · Received June 28, 2017

    Report

    Report Number
    3010617000-2017-00415
    Event Type
    Injury
    Date Received
    June 28, 2017
    Date of Event
    April 10, 2017
    Report Date
    June 28, 2017
    Manufacturer
    ZOLL CIRCULATION
    Product Code
    NCX
    UDI-DI
    00849111075046
    PMA / PMN Number
    K101987
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    HEALTH PROFESSIONAL

    Narratives

    Additional Manufacturer Narrative · 1

    THE ZOLL CATHETER IN COMPLAINT WILL NOT BE RETURNED FOR INVESTIGATION. THEREFORE, A PHYSICAL INVESTIGATION COULD NOT BE PERFORMED. A SUPPLEMENTAL REPORT WILL BE FILED IF THE PRODUCT IS RETURNED AND INVESTIGATION HAS BEEN COMPLETED. THE PATIENT WAS IN AN AUTO ACCIDENT AND SUSTAINED MULTIPLE SERIOUS INJURIES. VENOUS THROMBOEMBOLIC EVENTS (VTE) INCLUDING DEEP VENOUS THROMBOSIS (DVT) ARE COMMON AMONG PATIENTS WITH TRAUMATIC BRAIN INJURY (TBI). IF LEFT UNTREATED IT MAY RESULT IN LETHAL PULMONARY THROMBOEMBOLISM (PE). PREVIOUS STUDIES HAVE SUGGESTED THAT INTRACRANIAL HEMORRHAGE SERVES AS AN INDEPENDENT RISK FACTOR FOR THE DEVELOPMENT OF DVT. STUDIES WERE CONDUCTED TO DETERMINE THE ASSOCIATION OF TBI TO THE FORMATION OF DVT IRRESPECTIVE OF THE USE OF ANTICOAGULATION THERAPY. THE INCIDENCE OF DVT AMONG PATIENTS WITH TBI APPEARED TO BE HIGH. MULTIPLE STUDIES HAVE ADDRESSED DVT CHEMOPROPHYLAXIS TIMING IN TRAUMATIC BRAIN INJURIES. A COMPREHENSIVE LITERATURE REVIEW ON BRAIN INJURIES WAS PERFORMED AND TWENTY-THREE PUBLICATIONS INCLUDING MORE THAN 5,000 PATIENTS. IT WAS REPORTED THAT THE 54% HEAD INJURY PATIENTS HAD DEVELOPED DVT. [REIFF DA1, HARICHARAN RN, BULLINGTON NM, GRIFFIN RL, MCGWIN G JR, RUE LW 3RD. TRAUMATIC BRAIN INJURY IS ASSOCIATED WITH THE DEVELOPMENT OF DEEP VEIN THROMBOSIS INDEPENDENT OF PHARMACOLOGICAL PROPHYLAXIS. J TRAUMA. 2009 MAY; 66(5):1436-40]. IT WAS PUBLISHED THAT VTE AFTER TBI REPRESENTS A CLINICAL CHALLENGE. PHYSICIANS MUST BALANCE APPROPRIATE TIMING OF CHEMOPROPHYLAXIS WITH RISK OF INCREASED CEREBRAL HEMORRHAGE. ALTHOUGH TRAUMA IS A WELL-ESTABLISHED ETIOLOGY FOR THROMBOEMBOLIC EVENTS, ONLY IN THE PAST DECADE HAVE TBI PATIENTS BEEN RECOGNIZED WITH AN INCREASED RISK FOR VTE. THIS IS MOST LIKELY DUE TO LENGTHY HOSPITAL IMMOBILIZATION COMBINED WITH DELAYS IN VTE DRUG REGIMEN PROPHYLAXIS. ADDITIONALLY, THE NATIVE LEVELS OF CIRCULATING INFLAMMATORY CYTOKINES IN TBI PATIENTS FAVOR SYSTEMIC HYPERCOAGULATION. LITERATURE IMPLIES THAT IN PATIENTS WITH TBI, DVT CHEMOPROPHYLAXIS IS REASONABLE ON DAY 4. [HIBA ABDEL-AZIZ, C MICHAEL DUNHAM, REMA J MALIK, AND BARBARA M HILEMAN. TIMING FOR DEEP VEIN THROMBOSIS CHEMOPROPHYLAXIS IN TRAUMATIC BRAIN INJURY: AN EVIDENCE-BASED REVIEW. CRIT CARE. 2015; 19(1): 96.]. THE EVIDENCE HAS DIRECTED THE AMERICAN COLLEGE OF CHEST PHYSICIANS TO RECOMMEND PROPHYLAXIS AND TREATMENT OF VTE IN TBI PATIENTS. [STUART GLASSNER, D.O., KARAN SRIVASTAVA, PAUL COFNAS, BRIAN DEEGAN, PETER DEMARIA, RIMSKY DENIS, AND ENRIQUE GINZBURG, M.D. PREVENTION OF VENOUS THROMBOTIC EVENTS IN BRAIN INJURY: REVIEW OF CURRENT PRACTICES. RAMBAM MAIMONIDES MED J. 2013 JAN; 4(1)]. ANOTHER STUDY SHOWED THAT THE INCIDENCE OF DVT IN THE GENERAL NEUROSURGICAL POPULATION RANGES BETWEEN 19 AND 50%. [PIERCE C: SURVEILLANCE BIAS AND DEEP VEIN THROMBOSIS IN THE NATIONAL TRAUMA DATA BANK: THE MORE WE LOOK, THE MORE WE FIND. THE JOURNAL OF TRAUMA_ INJURY, INFECTION, AND CRITICAL CARE, 2007; SWANN KW, BLACK PM: DEEP VEIN THROMBOSIS AND PULMONARY EMBOLI IN NEUROSURGICAL PATIENTS: A REVIEW. J NEUROSURG 61:1055-1062, 1984]. COAGULOPATHY AND HEMOSTASIS IN MULTITRAUMA PATIENTS ARE ALSO KNOWN ISSUES AND DISCUSSED IN LITERATURE AND REMAIN AT THE FOREFRONT OF CLINICAL RESEARCH [DIANE A. SCHWARTZET ALL. MULTITRAUMA DERANGEMENTS IN HEMOSTASIS AND THROMBOSIS. HTTPS://ONCOHEMAKEY.COM/MULTITRAUMA-DERANGEMENTS-IN-HEMOSTASIS-AND-THROMBOSIS]. IN ADDITION, IT IS DISCUSSED THAT A SHOCK TOXIN DUE TO MULTIGRAIN INJURY IS THROMBOGENIC AND PATIENTS WITH MULTITRAUMA ARE PREDISPOSED TO DEVELOPMENT OF THROMBUS [1. ALFRED CUSCHIERI ET AL. MEDICAL CLINICAL SURGERY, 2003. PAGE 181]. AS A CONCLUSION, CONTRIBUTION OF THE COOL LINE CATHETER DUE TO THE REPORTED THROMBUS COULD NOT BE RULED OUT BECAUSE OF THE RELEVANT LOCATION AND TIMING (3 DAYS AFTER CATHETER REMOVAL). AT THE SAME TIME, THE PATIENT'S CLINICAL CONDITION OF HEAD TRAUMA AND MULTIGRAIN INJURY MADE THE PATIENT PREDISPOSED TO THROMBOGENICITY, AS A COMMON COMPLICATION IN SUCH PATIENTS. THE FETAL DEATH IS NOT RELATED TO THE DVT, AND MOST LIKELY CAUSE IS POOR HEALTH STATUS OF THE MOTHER DUE TO MULTIPLE SERIOUS INJURIES.

    Description of Event or Problem · 1

    IT WAS REPORTED THAT A PREGNANT PATIENT WHO WAS POLYTRAUMATIZED (TRAUMATIC SUBARACHNOID HEMORRHAGE AND DIFFUSED CEREBRAL CONTUSION) AS A RESULT OF AN AUTOMOBILE ACCIDENT WAS HOSPITALIZED. PATIENT COMORBIDITY WERE AS FOLLOWS: BILATERAL HEMOPNEUMOTHORAX, MULTIPLE FRACTURED RIBS, CLAVICLES, SCAPULAE, LUNG INJURY, LIVER INJURY. THE PATIENT, DURING HOSPITALIZATION, RECEIVED IVTM TREATMENT ON (B)(6) 2017 USING A COOL LINE CATHETER INSERTED IN THE RIGHT FEMORAL VEIN. FEVER CONTROL WAS PERFORMED USING THE IVTM FOR SEVEN DAYS AND COMPLETED ((B)(6) 2017). THE IVTM SYSTEM PERFORMED AS INTENDED WITHOUT ANY ISSUES. ACCORDING TO THE PHYSICIAN, HEPARIN WAS NOT ADMINISTERED DURING IVTM TREATMENT AS THE PATIENT WAS POLYTRAUMATIZED AND BLEEDING AT THAT TIME. ADDITIONAL INFORMATION RECEIVED STATED THAT ON (B)(6) 2017, AN ECHOCARDIOGRAM WAS PERFORMED AND THROMBUS WAS FOUND IN THE INFERIOR VENA CAVA. HEPARIN ANTI-COAGULANT TREATMENT WAS ADMINISTERED. ON (B)(6) 2017, DISAPPEARANCE OF THE THROMBUS WAS CONFIRMED. ON (B)(6) 2017, THE PATIENT SUFFERED A HEMORRHAGIC SHOCK. TRANSCATHETER ARTERIAL EMBOLIZATION (TAE) WAS PERFORMED FOR LEFT ILIOPSOAS MUSCLE BLEEDING. THE FETAL DEATH IN UTERO WAS CONFIRMED. NO FURTHER INFORMATION WAS PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    453615 ZOLL IVTM COOL LINE CATHETER CENTRAL VENOUS CATHETER NCX ZOLL CIRCULATION 8700-0654-01 UNK 00849111075046

    Patients

    Seq Age Sex Outcome Treatment
    1 38 YR Required Intervention